licensing

Coherus stock falls on Loqtorzi licensing (NASDAQ:CHRS)

phototechno Canadian drug developer Apotex on Tuesday announced an agreement with Coherus Biosciences (NASDAQ:CHRS) to buy Canadian rights to the former’s cancer therapy toripalimab, marketed in the U.S. as Loqtorzi for head and neck cancer. Under the agreement, Apotex will hold exclusive Canadian rights to toripalimab, an anti-PD-1 monoclonal antibodyContinue Reading

Meta may block news content on Facebook in Australia if forced to pay licensing fee

In: Finance

panida wijitpanya Meta Platforms (NASDAQ:META) will consider blocking all news content from Facebook in Australia if the government forces it to pay licensing fees to media outlets to display links, in line with the decision it took in Canada that implemented a similar law. “All options are on the table,”Continue Reading

Coherus stock falls on Loqtorzi licensing (NASDAQ:CHRS)

Meta may block news content on Facebook in Australia if forced to pay licensing fee

This “robot bird” flies at 45 mph through forests—With no GPS or light

Scientists freeze quantum motion using ultrafast laser trick